Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1
| Data(s) |
2013
|
|---|---|
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/53085/1/Optimizing%20Ribavirin.pdf Stickel, Felix; Worni, Mathias; Pache, Isabelle; Moradpour, Darius; Helbling, Beat; Borovicka, Jan; Gerlach, Tilman J (2013). Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1. American journal of gastroenterology, 108(7), pp. 1176-1178. Nature 10.1038/ajg.2013.140 <http://dx.doi.org/10.1038/ajg.2013.140> doi:10.7892/boris.53085 info:doi:10.1038/ajg.2013.140 urn:issn:0002-9270 |
| Idioma(s) |
eng |
| Publicador |
Nature |
| Relação |
http://boris.unibe.ch/53085/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Stickel, Felix; Worni, Mathias; Pache, Isabelle; Moradpour, Darius; Helbling, Beat; Borovicka, Jan; Gerlach, Tilman J (2013). Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1. American journal of gastroenterology, 108(7), pp. 1176-1178. Nature 10.1038/ajg.2013.140 <http://dx.doi.org/10.1038/ajg.2013.140> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion NonPeerReviewed |
